Insights

Innovative Lead Product Talphera's flagship candidate Niyad, a breakthrough anticoagulant for extracorporeal circuits, presents a significant opportunity for hospitals and surgical centers seeking advanced blood management solutions, especially given its FDA Breakthrough Device Designation.

Strategic Partnerships The company's development of pre-filled syringes in-licensed from Aguettant, such as Fedsyra and PFS-02, indicates potential upsell opportunities to existing partners and enhancements in emergency and hospital care product lines.

Recent Funding Boost With a recent $26 million capital influx through a mix of royalty monetization and equity, Talphera is well-positioned to accelerate sales efforts, expand its product portfolio, and penetrate additional medically supervised settings.

Leadership and Visibility The appointment of industry veteran Joe Todisco to the board bolsters credibility and opens doors for strategic alliances with other healthcare innovators, potentially leading to future sales collaborations.

Focus on Medically Supervised Settings Talphera’s emphasis on therapies designed for medically supervised environments suggests high-value sales opportunities with hospitals, clinics, and specialized treatment centers seeking novel, FDA-designated medical devices and drugs.

Similar companies to AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. Tech Stack

AcelRx Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, Open Graph, MySQL, and more. Explore AcelRx Pharmaceuticals, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Chosen
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology

AcelRx Pharmaceuticals, Inc.'s Email Address Formats

AcelRx Pharmaceuticals, Inc. uses at least 2 format(s):
AcelRx Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@acelrx.comJDoe@acelrx.com
91%
Last@acelrx.comDoe@acelrx.com
9%

Frequently Asked Questions

Where is AcelRx Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc.'s main headquarters is located at 1850 Gateway Drive San Mateo, California 94404 United States. The company has employees across 1 continents, including North America.

What is AcelRx Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact AcelRx Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AcelRx Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is TLPH.

What is AcelRx Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc.'s official website is talphera.com and has social profiles on LinkedInCrunchbase.

What is AcelRx Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AcelRx Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of March 2026, AcelRx Pharmaceuticals, Inc. has approximately 39 employees across 1 continents, including North America. Key team members include Chief Medical Officer: S. A.Vice President Regulatory Affairs And Quality Assurance: K. G.Head Of Program Management (consulting Basis): G. K.. Explore AcelRx Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does AcelRx Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does AcelRx Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc.'s tech stack includes WordPressOpen GraphMySQLoEmbedChosenjQuery MigratePHPX-Content-Type-Options.

What is AcelRx Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@acelrx.com. Find more AcelRx Pharmaceuticals, Inc. email formats with LeadIQ.

When was AcelRx Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
AcelRx Pharmaceuticals, Inc. was founded in 2005.

AcelRx Pharmaceuticals, Inc.

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera’s lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation Status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.  
 
To learn more about the development status of these product candidates, please visit our website at www.talphera.com.

Section iconCompany Overview

Headquarters
1850 Gateway Drive San Mateo, California 94404 United States
Phone number
Stock Symbol
TLPH
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M

    AcelRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    AcelRx Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.